LATITUDE Wave Communicators
FDA premarket approval P910077/S179 · decided 2020-06-12
Approval details
- PMA number
- P910077
- Supplement
- S179
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- LATITUDE Wave Communicators
- Generic name
- Implantable cardioverter defibrillator (non-CRT)
- Applicant
- Boston Scientific
- Date received
- 2020-05-14
- Decision date
- 2020-06-12
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- LWS
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- Alternate, functionally equivalent manufacturing line for LATITUDE Wave Communicator printed circuit assemblies.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.